Skip to content

Clinical trials

Phase 2 Tardive Dyskinesia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tardive Dyskinesia Phase: Phase 2 Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20091
20101
20112
20122
20141
20151
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Withdrawn2
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Neurocrine Biosciences5
Charite University, Berlin, Germany1
Medicure1
Synchroneuron Inc.1
Université de Montréal1
Woodinville Psychiatric Associates1
cerbomed GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tardive Dyskinesia11
Schizophrenia3
Movement Disorders2
Dementia1
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Dystonia1
Fibromyalgia1
Hallucinations1
Illusions1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.